Ignite Creation Date:
2025-12-25 @ 3:10 AM
Ignite Modification Date:
2026-01-04 @ 2:54 AM
Study NCT ID:
NCT05060705
Status:
NOT_YET_RECRUITING
Last Update Posted:
2024-04-17
First Post:
2021-09-24
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
"Efesovir" (FS-1) for COVID-19, Phase 2
Sponsor:
Scientific Center for Anti-infectious Drugs, Kazakhstan
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2025-12
Start Date Type:
ESTIMATED
Primary Completion Date:
2026-04
Primary Completion Date Type:
ESTIMATED
Completion Date:
2026-11
Completion Date Type:
ESTIMATED
First Submit Date:
2021-09-24
First Submit QC Date:
None
Study First Post Date:
2021-09-29
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-04-16
Last Update Post Date:
2024-04-17
Last Update Post Date Type:
ACTUAL